An en banc ruling by the U.S. Court of Appeals for the Federal Circuit has narrowed the reach of U.S. patent laws covering companies’ overseas sales and production.

The Wednesday decision in the closely watched Cardiac Pacemakers Inc. v. St. Jude Medical Inc. determined that patents for methods or processes are not subject to patent infringement liability if the products are assembled and sold overseas. Patents for products, however, are not exempt.